# Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing

> **NCT00698607** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 1466 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Everolimus-eluting stent (Xience or Promus)
- **DEVICE:** Sirolimus-eluting stent (Cypher)
- **DRUG:** 6-month clopidogrel therapy
- **DRUG:** 12-month clopidogrel therapy

## Key facts

- **NCT ID:** NCT00698607
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2013-12
- **Final completion:** 2014-04
- **Target enrollment:** 1466 (ACTUAL)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00698607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00698607, "Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00698607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*